As ectopic lipid accumulation in the liver closely correlates with insulin resistance and its decrease improves insulin sensitivity, our data suggest that increased liver insulin sensitivity after MitoTam administration could be in part responsible for its glucose-lowering effects. This evidence concerns the gene INS and Insulin resistance.